International Rx-to-OTC Switch Forecasts United Kingdom
Published May 2004
View
PDF brochure
The fifth report in Kline’s Rx-to-OTC-switch series
provides forecasts of switch-candidate brands and 14
therapeutic classes in United Kingdom from 2004 to 2009.
The study offers realistic, up-to-date forecasts based
on comprehensive primary research with industry executives.
It also provides insights on reimbursement and payers’
perspectives on switches, including direct input from
government health ministries, third-party payers, and
managed care organizations. The study includes a thorough
review of regulatory issues in United Kingdom and an
in-depth analysis of the retail environment for Rx-to-OTC
switches. (Y58107)
Australia
• Japan
• New
Zealand • France
• Germany
• Italy
• Canada
• United
States
Contact
|
